Kidney Hemodynamic Effects of Angiotensin Receptor Blockade, Sodium-Glucose Cotransporter-2 Inhibition Alone, and Their Combination: A Crossover Randomized Trial in People With Type 2 Diabetes

Circulation. 2022 Dec 13;146(24):1895-1897. doi: 10.1161/CIRCULATIONAHA.122.061033. Epub 2022 Dec 12.

¹ Diabetes Center, Department of Internal Medicine, Amsterdam University Medical Centers, Location VUMC, the Netherlands (R.A.S., A.C.H., C.M.M., D.H.v.R.).
² Division of Nephrology and Transplantation, Department of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, the Netherlands (F.G., E.J.H.).
³ Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, the Netherlands (D.J.T., H.J.L.H.).
⁴ Department of Nephrology and Hypertension, University Medical Center, Utrecht, the Netherlands (M.M.K., J.A.J.).

No abstract available

Keywords: angiotensin receptor blocker; diabetic kidney disease; sodium glucose cotransporter-2 inhibitor; type 2 diabetes mellitus.

Publication types